Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
about
JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expressionProtection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritisSynovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNAStaphylococcal peptidoglycans induce arthritisAnti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic miceAnti-cytokine therapy in chronic destructive arthritisAccelerated development of arthritis in mice lacking endothelial selectins.Bispecific digoxigenin-binding antibodies for targeted payload deliveryPotential therapeutic uses of interleukin 1 receptor antagonists in human diseases.The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.IL-1 has no direct role in the IGF-1 non-responsive state during experimentally induced arthritis in mouse knee joints.Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destructionAnti-interleukin 6 receptor antibody treatment in rheumatic disease.Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.Arguments for interleukin 1 as a target in chronic arthritis.VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritisLeukotriene B4 plays a critical role in the progression of collagen-induced arthritis.Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.Regulation of early complement components C3 and C4 in the synoviumInteractions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritisDevelopment of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.Repeated, but not acute, stress suppresses inflammatory plasma extravasation.Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cellsIL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.Evidence that cytokines play a role in rheumatoid arthritis.Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses.Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes.P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor.Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme.Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage.Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration.
P2860
Q24316553-23AAE7CE-1D36-44EF-B8C0-2B3AD6F64606Q24792053-FD3621F0-EE92-4071-88EE-41F31011FE88Q24792883-369B8913-334A-4087-AF2A-ED624A8BD3A8Q24799986-85D6E6CA-15CE-48E4-BA56-179E5F2BDAA5Q24801075-7E217611-43DE-4529-B643-9E48E3401C91Q24805245-59DF0208-7BD7-4EFD-83D0-4092572C6075Q24812222-5E7DB789-425B-4264-97BE-F8361E413CAAQ27667652-87A3F367-5C59-443D-9053-9D84F2629C9AQ30863549-D6910A15-C297-48A7-BFA0-CF46B55B0C17Q33566525-BB1FEF45-9E42-4A5F-995D-82D2D52C68B5Q33578584-8C9B4257-7CE3-4362-A27A-2294A5B1CCE7Q33782333-E3DC5F4B-E929-4EF2-B2F4-BD8F66ADE012Q34071253-1FE333EB-0076-47ED-A04C-D0D14AFE9AE7Q34071308-524FC0C8-ADC2-4C8B-82FC-69714836C312Q34071312-2D4ED180-F2C9-4A75-90CD-0EFC6F71FB06Q34217504-079A8197-23B1-44A7-A330-05678668AA94Q34420356-2CD237BA-2CC0-4F63-AE6D-82BE7EC85846Q34447437-ED8B6958-046A-4D37-8425-C9E0FAF4B4DEQ34775626-059C9AEA-EAFB-41DE-B10D-53A1F38CB5F0Q35041474-9051FF5B-1D83-490B-A0A8-28CB385D2232Q35225283-9A3FE909-D444-4978-80F6-89D394A36B85Q35630027-7875B98C-6906-48B8-A7F2-848C66613BA5Q35797922-D3BCA3D1-6E1B-4287-824C-1E905A2724D4Q36366486-EA93AAED-495F-40DE-A81B-634BD57FACD4Q36371110-78F3E151-491F-45C2-931C-71FDB0A48A60Q36375776-0B1AF139-A11B-423D-A3AD-825641725D6EQ36622363-268E64E6-AA58-46E6-8E1C-36B2E7DE16D4Q36751123-7D924753-2F82-41C3-A039-4A2A874D948DQ37008483-4CABFD41-3A2D-4C8D-AF7D-FAFD2BADCE88Q37202023-C2FEDBBB-7012-42FD-AA05-152308EB514FQ37316594-5C3AF370-374A-4ADF-880F-4BFC01DFB6A4Q38943162-5AC012A9-20DC-41D5-B1D0-796D1FD0190EQ39246542-9E0BB9F4-62E2-434E-A925-CD416BF69B5FQ39570137-17E160C0-4503-429A-8216-F9B1FC968C17Q40430530-54D49D56-E5B9-4D07-9DBD-B86464D47C98Q40576901-AAD9E628-4E83-4514-B62E-03B12D52A81FQ40684474-BA06D57B-F94F-4338-8BDD-454F8EE68226Q41832023-7D1AD38B-7A2A-410B-B796-BF73271124AAQ41837758-A9C8D967-7C52-4CE7-8BB5-4B154D152085Q42163509-3EF3419A-244B-4AC8-A601-1F3C027B750B
P2860
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@en
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@nl
type
label
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@en
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@nl
prefLabel
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@en
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@nl
P2093
P1476
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.
@en
P2093
Joosten LA
van de Loo FA
van den Berg WB
P304
P356
10.1111/J.1365-2249.1994.TB06517.X
P577
1994-02-01T00:00:00Z